Altered HOX and WNT7A expression in human lung cancer - PubMed (original) (raw)
. 2000 Nov 7;97(23):12776-81.
doi: 10.1073/pnas.97.23.12776.
J West, W Franklin, P Erickson, L Bemis, E Li, B Helfrich, P Bunn, J Roche, E Brambilla, R Rosell, R M Gemmill, H A Drabkin
Affiliations
- PMID: 11070089
- PMCID: PMC18840
- DOI: 10.1073/pnas.97.23.12776
Altered HOX and WNT7A expression in human lung cancer
R Calvo et al. Proc Natl Acad Sci U S A. 2000.
Abstract
HOX genes encode transcription factors that control patterning and cell fates. Alterations in HOX expression have been clearly implicated in leukemia, but their role in most other malignant diseases remains unknown. By using degenerate reverse transcription-PCR and subsequent real-time quantitative assays, we examined HOX expression in lung cancer cell lines, direct tumor-control pairs, and bronchial epithelial cultures. As in leukemia, genes of the HOX9 paralogous group and HOXA10 were frequently overexpressed. For HOXB9, we confirmed that elevated RNA was associated with protein overexpression. In some cases, marked HOX overexpression was associated with elevated FGF10 and FGF17. During development, the WNT pathway affects cell fate, polarity, and proliferation, and WNT7a has been implicated in the maintenance of HOX expression. In contrast to normal lung and mortal short-term bronchial epithelial cultures, WNT7a was frequently reduced or absent in lung cancers. In immortalized bronchial epithelial cells, WNT7a was lost concomitantly with HOXA1, and a statistically significant correlation between the expression of both genes was observed in lung cancer cell lines. Furthermore, we identified a homozygous deletion of beta-catenin in the mesothelioma, NCI-H28, associated with reduced WNT7a and the lowest overall cell line expression of HOXA1, HOXA7, HOXA9, and HOXA10, whereas HOXB9 levels were unaffected. Of note, both WNT7a and beta-catenin are encoded on chromosome 3p, which undergoes frequent loss of heterozygosity in these tumors. Our results suggest that alterations in regulatory circuits involving HOX, WNT, and possibly fibroblast growth factor pathways occur frequently in lung cancer.
Figures
Figure 1
RT-PCR amplification of HOX and FGF loci. (A) Degenerate RT-PCR products from the homeodomain (arrow) were amplified from nonmalignant (“normal”) lung, NHBE, two passages of T-antigen-immortalized bronchial epithelial cells (TR5214), and lung cancer cell lines. The leukemia line, MV4;11, is shown for comparison. (B) RT-PCR for FGF10 and FGF17 in lung tumor lines, a colorectal carcinoma, NCI-H630, and indicated controls.
Figure 2
(A) (Upper Left) Quantitative RT-PCR products for G3PDH, HOXA1, HOXA9, HOXA10, HOXB9, and WNT7a from NHBE cells and TR5214, passage 83. (Upper Right) Examples of quantitative RT-PCR products from tumor lines for HOXB9 and HOXA9. NT, no template. (Lower) Similar products shown for WNT7a. (B) Western blot for HOXB9. (Left) The indicated cell lines and direct tumor pair, as described in the text, were analyzed for the 30-kDa HOXB9 protein. Tubulin (55 kDa) served as a loading control. (Right) Identical Western blots contained (lane 1) 3-fold and (lane 2) 1-fold amounts of GST-HOXB9 fusion protein and (lane 3) tumor NCI-H513. No signal was observed for the endogenous HOXB9 (arrow) when the primary antibody was preincubated with GST-HOXB9-bound beads (blocked). (C) Southern blot demonstrating the specific absence of the β-catenin gene in _Eco_RI-digested genomic DNA from NCI-H28. A control probe (D3S30) is shown for comparison. Immunofluorescence confirmed loss of β-catenin protein in NCI-H28. Nuclei were visualized with 4′,6-diamidino-2-phenylindole (DAPI).
Figure 3
Correlation plots for HOX gene expression in cell lines. (A) ΔCt values for HOXA10 (x axis) are plotted against the sum of ΔCt values for all HOX loci analyzed (y axis). The trend line is shown along with the correlation coefficient (Pearson r = 0.77;P = 0.0001). (B) Similar analysis for HOXA1 (x axis) vs. WNT7a (y axis). In this case, the Spearman correlation coefficient is_r_ = 0.56 with P = 0.0038. Note that the trend line is skewed by the presence of one outlying data point.
Similar articles
- HOX transcription factors are potential targets and markers in malignant mesothelioma.
Morgan R, Simpson G, Gray S, Gillett C, Tabi Z, Spicer J, Harrington KJ, Pandha HS. Morgan R, et al. BMC Cancer. 2016 Feb 11;16:85. doi: 10.1186/s12885-016-2106-7. BMC Cancer. 2016. PMID: 26867567 Free PMC article. - Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
Xiao F, Bai Y, Chen Z, Li Y, Luo L, Huang J, Yang J, Liao H, Guo L. Xiao F, et al. Eur J Cancer. 2014 May;50(8):1541-54. doi: 10.1016/j.ejca.2014.01.024. Epub 2014 Feb 19. Eur J Cancer. 2014. PMID: 24559685 - HOX cofactors expression and regulation in the human ovary.
Ota T, Asahina H, Park SH, Huang Q, Minegishi T, Auersperg N, Leung PC. Ota T, et al. Reprod Biol Endocrinol. 2008 Oct 30;6:49. doi: 10.1186/1477-7827-6-49. Reprod Biol Endocrinol. 2008. PMID: 18973687 Free PMC article. - HOX genes and their role in the development of human cancers.
Bhatlekar S, Fields JZ, Boman BM. Bhatlekar S, et al. J Mol Med (Berl). 2014 Aug;92(8):811-23. doi: 10.1007/s00109-014-1181-y. Epub 2014 Jul 5. J Mol Med (Berl). 2014. PMID: 24996520 Review. - HOXA9 versus HOXB9; particular focus on their controversial role in tumor pathogenesis.
Hjazi A, Jasim SA, Al-Dhalimy AMB, Bansal P, Kaur H, Qasim MT, Mohammed IH, Deorari M, Jawad MA, Zwamel AH. Hjazi A, et al. J Appl Genet. 2024 Sep;65(3):473-492. doi: 10.1007/s13353-024-00868-x. Epub 2024 May 16. J Appl Genet. 2024. PMID: 38753266 Review.
Cited by
- Comprehensive in silico analysis of prognostic and immune infiltrates for FGFs in human ovarian cancer.
Wang Y, Zhang H, Zhan Y, Li Z, Li S, Guo S. Wang Y, et al. J Ovarian Res. 2024 Oct 9;17(1):197. doi: 10.1186/s13048-024-01496-z. J Ovarian Res. 2024. PMID: 39385288 Free PMC article. - Long Non-coding RNA HOXA11-AS Facilitates Proliferation of Lung Adenocarcinoma Cells via Targeting the Let-7c-5p/IGF2BP1 Axis.
Lv X, Fang Z, Qi W, Xu Y, Chen W. Lv X, et al. Front Genet. 2022 Mar 17;13:831397. doi: 10.3389/fgene.2022.831397. eCollection 2022. Front Genet. 2022. PMID: 35368660 Free PMC article. - Wnt7a inhibits transformed cell proliferation while promoting migration and invasion in non-small cell lung cancer.
Xu X, Xu S, Wei Z, Li J. Xu X, et al. Transl Cancer Res. 2020 Aug;9(8):4666-4675. doi: 10.21037/tcr-20-215. Transl Cancer Res. 2020. PMID: 35117830 Free PMC article. - Expression of the HOXA gene family and its relationship to prognosis and immune infiltrates in cervical cancer.
Ge F, Tie W, Zhang J, Zhu Y, Fan Y. Ge F, et al. J Clin Lab Anal. 2021 Nov;35(11):e24015. doi: 10.1002/jcla.24015. Epub 2021 Oct 4. J Clin Lab Anal. 2021. PMID: 34606634 Free PMC article. - The integrated stress response is tumorigenic and constitutes a therapeutic liability in KRAS-driven lung cancer.
Ghaddar N, Wang S, Woodvine B, Krishnamoorthy J, van Hoef V, Darini C, Kazimierczak U, Ah-Son N, Popper H, Johnson M, Officer L, Teodósio A, Broggini M, Mann KK, Hatzoglou M, Topisirovic I, Larsson O, Le Quesne J, Koromilas AE. Ghaddar N, et al. Nat Commun. 2021 Jul 30;12(1):4651. doi: 10.1038/s41467-021-24661-0. Nat Commun. 2021. PMID: 34330898 Free PMC article.
References
- Scott M P, Tamkun J W, Hartzell G W., III Biochim Biophys Acta. 1989;989:25–48. - PubMed
- Graham A, Papalopulu N, Krumlauf R. Cell. 1989;57:367–378. - PubMed
- Greer J M, Puetz J, Thomas K R, Capecchi M R. Nature (London) 2000;403:661–665. - PubMed
- Raza-Egilmez S Z, Jani-Sait S N, Grossi M, Higgins M J, Shows T B, Aplan P D. Cancer Res. 1998;58:4269–4273. - PubMed
- Nakamura T, Yamazaki Y, Hatano Y, Miura I. Blood. 1999;94:741–747. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials